D64.81 - Anemia due to antineoplastic chemotherapy
- Applicable to Anemia due to antineoplastic chemotherapy
- The 2025 edition of ICD10-CM D64.81 became effective on October 1, 2024.
- This is the American ICD10-CM version of D64.81 - other international versions of ICD10 D64.81 may differ.
- D64.81 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Antineoplastic chemotherapy induced anemia
Type 2 Excludes
- anemia in neoplastic disease (D63.0)
- aplastic anemia due to antineoplastic chemotherapy (D61.1)
Billable/Specific Code
The following codes above D64.81 contain annotation back-references that may be applicable to D64.81:
- Chapter: D50-D89 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Section: D60-D64 - Aplastic and other anemias and other bone marrow failure syndromes
- Category: D64 - Other anemias
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com